In early-stage tongue cancers, the aforementioned cathepsin K expression pattern predicted recurrence (HR 3.093, 95% CI [1.214–7.877]) and cancer-specific mortality (HR 9.306 95% CI [2.303–37.609]). Here, CTSK is linked to cancer.